<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35493076</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>03</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Print">2296-634X</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>10</Volume>
            <PubDate>
              <Year>2022</Year>
            </PubDate>
          </JournalIssue>
          <Title>Frontiers in cell and developmental biology</Title>
          <ISOAbbreviation>Front Cell Dev Biol</ISOAbbreviation>
        </Journal>
        <ArticleTitle><i>Chlamydia pneumoniae</i> Infection Induces Vascular Smooth Muscle Cell Migration and Atherosclerosis Through Mitochondrial Reactive Oxygen Species-Mediated JunB-Fra-1 Activation.</ArticleTitle>
        <Pagination>
          <StartPage>879023</StartPage>
          <MedlinePgn>879023</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">879023</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3389/fcell.2022.879023</ELocationID>
        <Abstract>
          <AbstractText>Infection is closely related to atherosclerosis, which is a major pathological basis for cardiovascular diseases. Vascular smooth muscle cell (VSMC) migration is an important trigger in development of atherosclerosis that is associated with <i>Chlamydia pneumoniae</i> (<i>C. pneumoniae</i>) infection. However, the mechanism of VSMC migration remains unclear, and whether antioxidant could be a therapeutic target for <i>C. pneumoniae</i> infection-induced atherosclerosis also remains unknown. The results showed that <i>C. pneumoniae</i> infection mainly impaired mitochondrial function and increased the level of mitochondrial reactive oxygen species (mtROS). The expressions of protein JunB, Fra-1 and Matrix metalloproteinase 2 (MMP) evidently increased after <i>C. pneumoniae</i> infection, and the interaction between JunB and Fra-1 was also enhanced. After scavenging mtROS by antioxidant Mito-TEMPO, the increasing expressions of JunB, Fra-1, MMP2 and the capacity of VSMC migration induced by <i>C. pneumoniae</i> infection were all inhibited. In comparison with infected ApoE<sup>-/-</sup> mice, the level of ROS in atherosclerotic lesion in ApoE<sup>-/-</sup>TLR2<sup>-/-</sup> mice with <i>C. pneumoniae</i> infection decreased. Knocking out TLR2 suppressed the expressions of JunB, Fra-1 and MMP2 in VSMCs and the formation of atherosclerotic lesion after <i>C. pneumoniae</i> infection. Furthermore, after using small interfering RNA to inhibit the expression of TLR2, the level of mtROS and the expressions of JunB, Fra-1 and MMP2 apparently decreased. Taken together, <i>C. pneumoniae</i> infection may promote VSMC migration and atherosclerosis development by increasing the level of mtROS through TLR2 to activate the JunB-Fra-1/MMP2 signaling pathway. The data provide the first evidence that antioxidant could reduce <i>C. pneumoniae</i> infection-induced VSMC migration and atherosclerosis.</AbstractText>
          <CopyrightInformation>Copyright © 2022 Zhao, Miao, Zhang, Zhang, Zhao, Xu, Wang and Zhang.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Xi</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Miao</LastName>
            <ForeName>Guolin</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute of Cardiovascular Sciences and Key Laboratory of Molecular Cardiovascular Sciences, Ministry of Education, Peking University, Beijing, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Lijun</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Yuke</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhao</LastName>
            <ForeName>Huanhuan</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Xu</LastName>
            <ForeName>Zhelong</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Beibei</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Lijun</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>12</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Front Cell Dev Biol</MedlineTA>
        <NlmUniqueID>101630250</NlmUniqueID>
        <ISSNLinking>2296-634X</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Activator protein 1</Keyword>
        <Keyword MajorTopicYN="N">Chlamydia pneumloniae</Keyword>
        <Keyword MajorTopicYN="N">atheroclerosis</Keyword>
        <Keyword MajorTopicYN="N">mitochondrial reactive oxygen species</Keyword>
        <Keyword MajorTopicYN="N">vascular smooth muscle cell</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>16</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35493076</ArticleId>
        <ArticleId IdType="pmc">PMC9039263</ArticleId>
        <ArticleId IdType="doi">10.3389/fcell.2022.879023</ArticleId>
        <ArticleId IdType="pii">879023</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
Atkinson T., Packwood W., Xie A., Liang S., Qi Y., Ruggeri Z., et al.  (2018). Assessment of Novel Antioxidant Therapy in Atherosclerosis by Contrast Ultrasound Molecular Imaging. J. Am. Soc. Echocardiogr.
31 (11), 1252–1259. 10.1016/j.echo.2018.07.017
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.echo.2018.07.017</ArticleId>
            <ArticleId IdType="pmc">PMC6218294</ArticleId>
            <ArticleId IdType="pubmed">30213420</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Bai F., Liu K., Li H., Wang J., Zhu J., Hao P., et al.  (2018). Veratramine Modulates AP-1-dependent Gene Transcription by Directly Binding to Programmable DNA. Nucleic Acids Res.
46 (2), 546–557. 10.1093/nar/gkx1241
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gkx1241</ArticleId>
            <ArticleId IdType="pmc">PMC5778533</ArticleId>
            <ArticleId IdType="pubmed">29237043</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Bakiri L., Macho-Maschler S., Custic I., Niemiec J., Guío-Carrión A., Hasenfuss S. C., et al.  (2015). Fra-1/AP-1 Induces EMT in Mammary Epithelial Cells by Modulating Zeb1/2 and TGFβ Expression. Cell Death Differ.
22 (2), 336–350. 10.1038/cdd.2014.157
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/cdd.2014.157</ArticleId>
            <ArticleId IdType="pmc">PMC4291495</ArticleId>
            <ArticleId IdType="pubmed">25301070</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Bakiri L., Matsuo K., Wisniewska M., Wagner E. F., Yaniv M. (2002). Promoter Specificity and Biological Activity of Tethered AP-1 Dimers. Mol. Cel. Biol.
22 (13), 4952–4964. 10.1128/mcb.22.13.4952-4964.2002
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mcb.22.13.4952-4964.2002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Balaban R. S., Nemoto S., Finkel T. (2005). Mitochondria, Oxidants, and Aging. Cell
120 (4), 483–495. 10.1016/j.cell.2005.02.001
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2005.02.001</ArticleId>
            <ArticleId IdType="pubmed">15734681</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Bennett M. R., Sinha S., Owens G. K. (2016). Vascular Smooth Muscle Cells in Atherosclerosis. Circ. Res.
118 (4), 692–702. 10.1161/CIRCRESAHA.115.306361
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCRESAHA.115.306361</ArticleId>
            <ArticleId IdType="pmc">PMC4762053</ArticleId>
            <ArticleId IdType="pubmed">26892967</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Bergman M. R., Cheng S., Honbo N., Piacentini L., Karliner J. S., Lovett D. H. (2003). A Functional Activating Protein 1 (AP-1) Site Regulates Matrix Metalloproteinase 2 (MMP-2) Transcription by Cardiac Cells through Interactions with JunB-Fra1 and JunB-FosB Heterodimers. Biochem. J.
369 (Pt 3), 485–496. 10.1042/BJ20020707
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/BJ20020707</ArticleId>
            <ArticleId IdType="pmc">PMC1223099</ArticleId>
            <ArticleId IdType="pubmed">12371906</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Bonnans C., Chou J., Werb Z. (2014). Remodelling the Extracellular Matrix in Development and Disease. Nat. Rev. Mol. Cel Biol.
15 (12), 786–801. 10.1038/nrm3904
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrm3904</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Brophy M. L., Dong Y., Tao H., Yancey P. G., Song K., Zhang K., et al.  (2019). Myeloid-Specific Deletion of Epsins 1 and 2 Reduces Atherosclerosis by Preventing LRP-1 Downregulation. Circ. Res.
124 (4), e6–e19. 10.1161/CIRCRESAHA.118.313028
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCRESAHA.118.313028</ArticleId>
            <ArticleId IdType="pmc">PMC6375743</ArticleId>
            <ArticleId IdType="pubmed">30595089</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Cao D., Wu Y., Jia Z., Zhao D., Zhang Y., Zhou T., et al.  (2019). 18β-glycyrrhetinic Acid Inhibited Mitochondrial Energy Metabolism and Gastric Carcinogenesis through Methylation-Regulated TLR2 Signaling Pathway. Carcinogenesis
40 (2), 234–245. 10.1093/carcin/bgy150
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/carcin/bgy150</ArticleId>
            <ArticleId IdType="pubmed">30364936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Cao H., Dronadula N., Rao G. N. (2006). Thrombin Induces Expression of FGF-2 via Activation of PI3K-Akt-Fra-1 Signaling axis Leading to DNA Synthesis and Motility in Vascular Smooth Muscle Cells. Am. J. Physiology-Cell Physiol.
290 (1), C172–C182. 10.1152/ajpcell.00284.2005
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpcell.00284.2005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chappell J., Harman J. L., Narasimhan V. M., Yu H., Foote K., Simons B. D., et al.  (2016). Extensive Proliferation of a Subset of Differentiated, yet Plastic, Medial Vascular Smooth Muscle Cells Contributes to Neointimal Formation in Mouse Injury and Atherosclerosis Models. Circ. Res.
119 (12), 1313–1323. 10.1161/CIRCRESAHA.116.309799
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCRESAHA.116.309799</ArticleId>
            <ArticleId IdType="pmc">PMC5149073</ArticleId>
            <ArticleId IdType="pubmed">27682618</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chen Y., Li S., Guo Y., Yu H., Bao Y., Xin X., et al.  (2020). Astaxanthin Attenuates Hypertensive Vascular Remodeling by Protecting Vascular Smooth Muscle Cells from Oxidative Stress-Induced Mitochondrial Dysfunction. Oxid. Med. Cell Longev.
2020, 1–19. 10.1155/2020/4629189
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2020/4629189</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Cheriyath V., Kaur J., Davenport A., Khalel A., Chowdhury N., Gaddipati L. (2018). G1P3 (IFI6), a Mitochondrial Localised Antiapoptotic Protein, Promotes Metastatic Potential of Breast Cancer Cells through mtROS. Br. J. Cancer
119 (1), 52–64. 10.1038/s41416-018-0137-3
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41416-018-0137-3</ArticleId>
            <ArticleId IdType="pmc">PMC6035266</ArticleId>
            <ArticleId IdType="pubmed">29899394</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chou C.-C., Wang C.-P., Chen J.-H., Lin H.-H. (2019). Anti-Atherosclerotic Effect of hibiscus Leaf Polyphenols against Tumor Necrosis Factor-Alpha-Induced Abnormal Vascular Smooth Muscle Cell Migration and Proliferation. Antioxidants
8 (12), 620. 10.3390/antiox8120620
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/antiox8120620</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Eferl R., Wagner E. F. (2003). AP-1: A Double-Edged Sword in Tumorigenesis. Nat. Rev. Cancer
3 (11), 859–868. 10.1038/nrc1209
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrc1209</ArticleId>
            <ArticleId IdType="pubmed">14668816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Farzaneh-Far A., Davies J. D., Braam L. A., Spronk H. M., Proudfoot D., Chan S.-W., et al.  (2001). A Polymorphism of the Human Matrix γ-Carboxyglutamic Acid Protein Promoter Alters Binding of an Activating Protein-1 Complex and Is Associated with Altered Transcription and Serum Levels. J. Biol. Chem.
276 (35), 32466–32473. 10.1074/jbc.M104909200
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M104909200</ArticleId>
            <ArticleId IdType="pubmed">11425864</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Gaude E., Schmidt C., Gammage P. A., Dugourd A., Blacker T., Chew S. P., et al.  (2018). NADH Shuttling Couples Cytosolic Reductive Carboxylation of Glutamine with Glycolysis in Cells with Mitochondrial Dysfunction. Mol. Cel.
69 (4), 581–593. 10.1016/j.molcel.2018.01.034
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molcel.2018.01.034</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Gaydos C. A., Summersgill J. T., Sahney N. N., Ramirez J. A., Quinn T. C. (1996). Replication of Chlamydia Pneumoniae In Vitro in Human Macrophages, Endothelial Cells, and Aortic Artery Smooth Muscle Cells. Infect. Immun.
64 (5), 1614–1620. 10.1128/IAI.64.5.1614-1620.1996
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.64.5.1614-1620.1996</ArticleId>
            <ArticleId IdType="pmc">PMC173970</ArticleId>
            <ArticleId IdType="pubmed">8613369</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hynes R. O. (2009). The Extracellular Matrix: Not Just Pretty Fibrils. Science
326 (5957), 1216–1219. 10.1126/science.1176009
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1176009</ArticleId>
            <ArticleId IdType="pmc">PMC3536535</ArticleId>
            <ArticleId IdType="pubmed">19965464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kim J. D., Yoon N. A., Jin S., Diano S. (2019). Microglial UCP2 Mediates Inflammation and Obesity Induced by High-Fat Feeding. Cel Metab.
30 (5), 952–962. 10.1016/j.cmet.2019.08.010
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2019.08.010</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kumar R., Mani A. M., Singh N. K., Rao G. N. (2020). PKCθ-JunB axis via Upregulation of VEGFR3 Expression Mediates Hypoxia-Induced Pathological Retinal Neovascularization. Cell Death Dis.
11 (5), 325. 10.1038/s41419-020-2522-0
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41419-020-2522-0</ArticleId>
            <ArticleId IdType="pmc">PMC7206019</ArticleId>
            <ArticleId IdType="pubmed">32382040</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Li B., Wan Z., Wang Z., Zuo J., Xu Y., Han X., et al.  (2020a). TLR2 Signaling Pathway Combats streptococcus Uberis Infection by Inducing Mitochondrial Reactive Oxygen Species Production. Cells
9 (2), 494. 10.3390/cells9020494
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/cells9020494</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Li B., Xia Y., Hu B. (2020b). Infection and Atherosclerosis: TLR-Dependent Pathways. Cell. Mol. Life Sci.
77 (14), 2751–2769. 10.1007/s00018-020-03453-7
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00018-020-03453-7</ArticleId>
            <ArticleId IdType="pmc">PMC7223178</ArticleId>
            <ArticleId IdType="pubmed">32002588</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Li P., Zhu N., Yi B., Wang N., Chen M., You X., et al.  (2013). MicroRNA-663 Regulates Human Vascular Smooth Muscle Cell Phenotypic Switch and Vascular Neointimal Formation. Circ. Res.
113 (10), 1117–1127. 10.1161/CIRCRESAHA.113.301306
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCRESAHA.113.301306</ArticleId>
            <ArticleId IdType="pmc">PMC4537615</ArticleId>
            <ArticleId IdType="pubmed">24014830</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Li X., Fang P., Li Y., Kuo Y.-M., Andrews A. J., Nanayakkara G., et al.  (2016). Mitochondrial Reactive Oxygen Species Mediate Lysophosphatidylcholine-Induced Endothelial Cell Activation. Atvb
36 (6), 1090–1100. 10.1161/ATVBAHA.115.306964
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/ATVBAHA.115.306964</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Liu H., Xiang H., Zhao S., Sang H., Lv F., Chen R., et al.  (2019). Vildagliptin Improves High Glucose-Induced Endothelial Mitochondrial Dysfunction via Inhibiting Mitochondrial Fission. J. Cel. Mol. Med.
23 (2), 798–810. 10.1111/jcmm.13975
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jcmm.13975</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Liu Y. D., Yu L., Ying L., Balic J., Gao H., Deng N. T., et al.  (2019). Toll‐like Receptor 2 Regulates Metabolic Reprogramming in Gastric Cancer via Superoxide Dismutase 2. Int. J. Cancer
144 (12), 3056–3069. 10.1002/ijc.32060
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ijc.32060</ArticleId>
            <ArticleId IdType="pmc">PMC6590666</ArticleId>
            <ArticleId IdType="pubmed">30536754</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Ma L., Zhang L., Wang B., Wei J., Liu J., Zhang L. (2015). Berberine Inhibits Chlamydia Pneumoniae Infection-Induced Vascular Smooth Muscle Cell Migration through Downregulating MMP3 and MMP9 via PI3K. Eur. J. Pharmacol.
755, 102–109. 10.1016/j.ejphar.2015.02.039
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejphar.2015.02.039</ArticleId>
            <ArticleId IdType="pubmed">25746423</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Meng X., Piao L., Wang H., Inoue A., Huang Z., Jiang H., et al.  (2020). Deficiency of Cysteinyl Cathepsin K Suppresses the Development of Experimental Intimal Hyperplasia in Response to Chronic Stress. J. Hypertens.
38 (8), 1514–1524. 10.1097/HJH.0000000000002424
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/HJH.0000000000002424</ArticleId>
            <ArticleId IdType="pubmed">32205563</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Miao G., Zhao X., Wang B., Zhang L., Wang G., Zheng N., et al.  (2020). TLR2/CXCR4 Coassociation facilitatesChlamydia Pneumoniaeinfection-Induced Atherosclerosis. Am. J. Physiol.-Heart Circul. Physiol.
318 (6), H1420–H1435. 10.1152/ajpheart.00011.2020
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpheart.00011.2020</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Miyake T., Shirakawa H., Nakagawa T., Kaneko S. (2015). Activation of Mitochondrial Transient Receptor Potential Vanilloid 1 Channel Contributes to Microglial Migration. Glia
63 (10), 1870–1882. 10.1002/glia.22854
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/glia.22854</ArticleId>
            <ArticleId IdType="pubmed">26010461</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Moss J. W. E., Ramji D. P. (2016). Nutraceutical Therapies for Atherosclerosis. Nat. Rev. Cardiol.
13 (9), 513–532. 10.1038/nrcardio.2016.103
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrcardio.2016.103</ArticleId>
            <ArticleId IdType="pmc">PMC5228762</ArticleId>
            <ArticleId IdType="pubmed">27383080</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Naiki Y., Sorrentino R., Wong M. H., Michelsen K. S., Shimada K., Chen S., et al.  (2008). TLR/MyD88 and Liver X Receptor α Signaling Pathways Reciprocally ControlChlamydia Pneumoniae-Induced Acceleration of Atherosclerosis. J. Immunol.
181 (10), 7176–7185. 10.4049/jimmunol.181.10.7176
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.181.10.7176</ArticleId>
            <ArticleId IdType="pmc">PMC2683843</ArticleId>
            <ArticleId IdType="pubmed">18981139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Park S. L., Won S. Y., Song J.-H., Kambe T., Nagao M., Kim W.-J., et al.  (2015). EPO Gene Expression Promotes Proliferation, Migration and Invasion via the p38MAPK/AP-1/MMP-9 Pathway by p21WAF1 Expression in Vascular Smooth Muscle Cells. Cell Signal.
27 (3), 470–478. 10.1016/j.cellsig.2014.12.001
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cellsig.2014.12.001</ArticleId>
            <ArticleId IdType="pubmed">25496832</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Pothineni N. V. K., Subramany S., Kuriakose K., Shirazi L. F., Romeo F., Shah P. K., et al.  (2017). Infections, Atherosclerosis, and Coronary Heart Disease. Eur. Heart J.
38 (43), 3195–3201. 10.1093/eurheartj/ehx362
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/eurheartj/ehx362</ArticleId>
            <ArticleId IdType="pubmed">29020241</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Roufaiel M., Gracey E., Siu A., Zhu S.-N., Lau A., Ibrahim H., et al.  (2016). CCL19-CCR7-dependent Reverse Transendothelial Migration of Myeloid Cells Clears Chlamydia Muridarum from the Arterial Intima. Nat. Immunol.
17 (11), 1263–1272. 10.1038/ni.3564
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ni.3564</ArticleId>
            <ArticleId IdType="pubmed">27668800</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Schraml B. U., Hildner K., Ise W., Lee W.-L., Smith W. A.-E., Solomon B., et al.  (2009). The AP-1 Transcription Factor Batf Controls TH17 Differentiation. Nature
460 (7253), 405–409. 10.1038/nature08114
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature08114</ArticleId>
            <ArticleId IdType="pmc">PMC2716014</ArticleId>
            <ArticleId IdType="pubmed">19578362</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Shaulian E., Karin M. (2002). AP-1 as a Regulator of Cell Life and Death. Nat. Cel Biol.
4 (5), E131–E136. 10.1038/ncb0502-e131
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncb0502-e131</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Suresh K., Servinsky L., Jiang H., Bigham Z., Zaldumbide J., Huetsch J. C., et al.  (2019). Regulation of Mitochondrial Fragmentation in Microvascular Endothelial Cells Isolated from the SU5416/hypoxia Model of Pulmonary Arterial Hypertension. Am. J. Physiology-Lung Cell Mol. Physiol.
317 (5), L639–L652. 10.1152/ajplung.00396.2018
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajplung.00396.2018</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Tyrrell D. J., Blin M. G., Song J., Wood S. C., Zhang M., Beard D. A., et al.  (2020). Age-Associated Mitochondrial Dysfunction Accelerates Atherogenesis. Circ. Res.
126 (3), 298–314. 10.1161/CIRCRESAHA.119.315644
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCRESAHA.119.315644</ArticleId>
            <ArticleId IdType="pmc">PMC7006722</ArticleId>
            <ArticleId IdType="pubmed">31818196</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Virani S. S., Alonso A., Benjamin E. J., Bittencourt M. S., Callaway C. W., Carson A. P., et al.  (2020). Heart Disease and Stroke Statistics-2020 Update: A Report from the American Heart Association. Circulation
141 (9), e139–e596. 10.1161/CIR.0000000000000757
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIR.0000000000000757</ArticleId>
            <ArticleId IdType="pubmed">31992061</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wang A., Al-Kuhlani M., Johnston S. C., Ojcius D. M., Chou J., Dean D. (2013). Transcription Factor Complex AP-1 Mediates Inflammation Initiated byChlamydia Pneumoniaeinfection. Cell. Microbiol.
15 (5), 779–794. 10.1111/cmi.12071
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/cmi.12071</ArticleId>
            <ArticleId IdType="pmc">PMC3593943</ArticleId>
            <ArticleId IdType="pubmed">23163821</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wang B., Zhang L., Liu J., Ma L., Wang H., Zheng N., et al.  (2017). Chlamydia Pneumoniae Infection Promotes Vascular Endothelial Cell Angiogenesis through an IQGAP1-Related Signaling Pathway. Int. J. Med. Microbiol.
307 (4-5), 276–286. 10.1016/j.ijmm.2017.03.001
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijmm.2017.03.001</ArticleId>
            <ArticleId IdType="pubmed">28377051</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wang C., Li Z., Shao F., Yang X., Feng X., Shi S., et al.  (2017). High Expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) Facilitates Progression of Oesophageal Squamous Cell Carcinoma through MAPK/MEK/ERK/FRA-1 Activation. J. Exp. Clin. Cancer Res.
36 (1), 84. 10.1186/s13046-017-0555-8
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13046-017-0555-8</ArticleId>
            <ArticleId IdType="pmc">PMC5481965</ArticleId>
            <ArticleId IdType="pubmed">28645305</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wang Y., Wu T., Tang M. (2020). Ambient Particulate Matter Triggers Dysfunction of Subcellular Structures and Endothelial Cell Apoptosis through Disruption of Redox Equilibrium and Calcium Homeostasis. J. Hazard. Mater.
394, 122439. 10.1016/j.jhazmat.2020.122439
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhazmat.2020.122439</ArticleId>
            <ArticleId IdType="pubmed">32200236</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wei Y., Corbalán-Campos J., Gurung R., Natarelli L., Zhu M., Exner N., et al.  (2018). Dicer in Macrophages Prevents Atherosclerosis by Promoting Mitochondrial Oxidative Metabolism. Circulation
138 (18), 2007–2020. 10.1161/CIRCULATIONAHA.117.031589
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCULATIONAHA.117.031589</ArticleId>
            <ArticleId IdType="pubmed">29748186</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
West A. P., Brodsky I. E., Rahner C., Woo D. K., Erdjument-Bromage H., Tempst P., et al.  (2011). TLR Signalling Augments Macrophage Bactericidal Activity through Mitochondrial ROS. Nature
472 (7344), 476–480. 10.1038/nature09973
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature09973</ArticleId>
            <ArticleId IdType="pmc">PMC3460538</ArticleId>
            <ArticleId IdType="pubmed">21525932</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wu H., Cheng X. W., Hu L., Takeshita K., Hu C., Du Q., et al.  (2016). Cathepsin S Activity Controls Injury-Related Vascular Repair in Mice via the TLR2-Mediated p38MAPK and PI3K−Akt/p-HDAC6 Signaling Pathway. Atvb
36 (8), 1549–1557. 10.1161/ATVBAHA.115.307110
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/ATVBAHA.115.307110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Yamada K. M., Sixt M. (2019). Mechanisms of 3D Cell Migration. Nat. Rev. Mol. Cel Biol.
20 (12), 738–752. 10.1038/s41580-019-0172-9
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41580-019-0172-9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Yu L., Liang Q., Zhang W., Liao M., Wen M., Zhan B., et al.  (2019). HSP22 Suppresses Diabetes-Induced Endothelial Injury by Inhibiting Mitochondrial Reactive Oxygen Species Formation. Redox Biol.
21, 101095. 10.1016/j.redox.2018.101095
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.redox.2018.101095</ArticleId>
            <ArticleId IdType="pmc">PMC6327915</ArticleId>
            <ArticleId IdType="pubmed">30640127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Zheng N., Zhang L., Wang B., Wang G., Liu J., Miao G., et al.  (2019). Chlamydia Pneumoniae Infection Promotes Vascular Smooth Muscle Cell Migration via C-Fos/interleukin-17C Signaling. Int. J. Med. Microbiol.
309, 151340. 10.1016/j.ijmm.2019.151340
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijmm.2019.151340</ArticleId>
            <ArticleId IdType="pubmed">31494039</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Zhu J., Liu B., Wang Z., Wang D., Ni H., Zhang L., et al.  (2019). Exosomes from Nicotine-Stimulated Macrophages Accelerate Atherosclerosis through miR-21-3p/PTEN-Mediated VSMC Migration and Proliferation. Theranostics
9 (23), 6901–6919. 10.7150/thno.37357
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7150/thno.37357</ArticleId>
            <ArticleId IdType="pmc">PMC6815950</ArticleId>
            <ArticleId IdType="pubmed">31660076</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
